Tumour necrosis factor (TNF) antagonists for inflammatory bowel disease

Examples

Generic Name	Brand Name
adalimumab	Humira
infliximab	Remicade

How It Works

Infliximab is an that inhibits tumour necrosis factor, a protein that increases inflammation in the body. Infliximab blocks the inflammatory response that happens in and . It is given in a vein (intravenously, IV).

A tumour necrosis factor (TNF) antagonist is a type of antibody that inhibits tumour necrosis factor, a protein that increases inflammation in the body. Infliximab and adalimumab block the inflammatory response that happens in Crohn's disease and ulcerative colitis. They are both given as a shot. Infliximab is given as a shot in a vein (intravenous, or IV) and adalimumab is given as a shot under the skin (subcutaneous).

Why It Is Used

Infliximab was first used to treat abnormal connections (fistulas) between the intestines and organs in moderate to severe Crohn's disease. Now it is used to induce and maintain remission (a period without symptoms) in people who have Crohn's disease or ulcerative colitis that has not improved with other medicines.

Adalimumab is used to induce and maintain remission in people with Crohn's disease who have not improved with other medicines and who no longer respond to or cannot tolerate treatment with infliximab.

How Well It Works

Infliximab can cause remission in people with moderate to severe Crohn's disease, including the closing of fistulas. In one study, some people who were treated with infliximab had symptoms that came back after 3 months. It is now recommended that people treated with infliximab continue to get the medicine at regular intervals. This is called maintenance therapy.

In multiple studies, almost 70% of people taking infliximab had fewer symptoms or had healed fistulas.¹

In one study, between 60% and 70% of people with ulcerative colitis were better 8 weeks after getting infliximab treatment. In another study, twice as many people got better after receiving infliximab compared to those taking a placebo.²

Adalimumab has shown promise in treating Crohn's disease in multiple studies.³ It works like infliximab and may be good for people who are allergic to infliximab.

The long-term effectiveness of both medicines is still being studied.

Side Effects

The most common side effect of TNF antagonists is an allergic reaction to the injection (shot) or infusion (IV). If you have a reaction to the shot or infusion, it will happen right away, either during the infusion or within 1 to 2 hours after the infusion or shot. Your doctor may give you medicines to prevent or stop the reaction.

Symptoms of an infusion site reaction include:

• Fever.
• Chills.
• Chest pain.
• Shortness of breath.
• Itching (pruritis).
• Headache.
• Nausea.
• Heat and redness (flushing) in the face.
• Rash.
• Fatigue.
• Dizziness.

Warnings about serious side effects of TNF antagonists have been issued. The drugs' manufacturers have warned about:

• An increased risk of a serious infection (such as tuberculosis). If you have had tuberculosis (TB) or know someone who has, tell your health professional. TNF antagonists also affect your body's ability to fight all infections, so if get a fever, cold, or the flu while taking one of these medicines, let your health professional know right away.
• An increased risk of blood or nervous system disorders. Call your doctor if you have symptoms of blood disorders (such as bruising or bleeding) or symptoms of nervous system problems (such as numbness, weakness, tingling, or vision problems).
• A possible increased risk of lymphoma (a type of blood cancer). It is not clear whether this increase is because of the drug or because people with this disease may already have a higher risk. There have been reports of a rare kind of lymphoma, occurring mostly in children and teens taking TNF antagonists, that often results in death.
• An increased risk of liver injuries. Call your health professional if your skin starts to look yellow, if you are very tired, or if you have a fever or dark brown urine.

See Drug Reference for a full list of side effects. (Drug Reference is not available in all systems.)

What To Think About

Infliximab is more expensive than other medicines used to treat Crohn's disease.

This medicine is used for Crohn's disease and ulcerative colitis that has not improved (refractory disease) when treated with corticosteroids, aminosalicylates, antibiotics, azathioprine, or 6-mercaptopurine. Infliximab is recommended to be used when other medicines don't work.

The use of infliximab during pregnancy is still being studied. It may be used when other medicines have not worked and the health of the mother or of the fetus (or both) is at risk. It is not known if infliximab can pass from the mother to the baby in breast milk. If you have inflammatory bowel disease and you are pregnant, thinking about becoming pregnant, or breast-feeding, talk to your doctor about what medicines are safe for you to use.

Because adalimumab is given as a shot under the skin, you may be able to do the shots yourself once your doctor has shown you how.

Complete the new medication information form (PDF)(What is a PDF document?) to help you understand this medication.

Author:	Douglas Dana Monica Rhodes	Last Updated: February 1, 2007
Medical Review:	Kathleen Romito, MD - Family Medicine Andrew Swan, MD, CCFP, FCFP - Family Medicine Arvydas D. Vanagunas, MD - Gastroenterology
© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.